New Mexico lawmakers injected a dose of political pressure Monday into an unwavering but so far unsuccessful effort to add opioid use disorder to the list of qualifying conditions for medical cannabis in New Mexico.
Tag Archives: Opioid
A bill that would allow people who have been prescribed opioids to apply for a temporary medical marijuana card passed a Senate committee Wednesday.
Seniors are consuming more marijuana to help manage their pain. Could medical marijuana help some people replace their opioid prescriptions?
Today, Americans for Safe Access released “Medical Cannabis as a Tool to Combat Pain and the Opioid Crisis: A Blueprint for State Policy.” The blueprint outlines legislative and regulatory solutions related to medical cannabis that states can utilize to combat the opioid epidemic.
TALLAHASSEE, Fla., Nov. 2, 2017 /Weed Wire/ — This morning Senator Farmer filed SB 726, a bill to legalize the smoking of marijuana for medical use.
SEATTLE, Nov. 2, 2017 /Weed Wire/ — CFN Media Group (“CannabisFN”), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Corix Biosciences Inc. (OTCQX: CXBS) and its focus on standardized tissue culture propagation of cannabidiol, hemp, and cannabis genetics.
CHICAGO, Nov. 1, 2017 /Weed Wire/ — Aclara Research, a leader in the development of patient and consumer insights within the cannabis industry, today released the preliminary results of their latest study examining patient usage of medical cannabis and the impact on prescription opioid usage.
Shares of Insys Therapeutics, a small-cap biotech with a focus on pain management, plunged as much as 30% on Wednesday after receiving a double whammy.
DENVER, Oct. 26, 2017 /Weed Wire/ — Five years ago this November, Colorado citizens voted to pass Amendment 64, the legislative act which legalized adult-use marijuana in the Centennial State.
WASHINGTON, Sept. 19, 2017 /Weed Wire/ — Today Councilmember David Grosso (I-At Large) introduced two bills to address the opioid crisis in the District of Columbia.
DENVER, Sept. 1, 2017 /Weed Wire/ – The Cannabis Business Alliance (CBA) has released a statement in response to a recent report by anti-legalization organ SAM that attempts to claim that states that provide legal cannabis have failed to comply with the Cole Memo.
You don’t have to be Nostradamus to successfully predict that more states will legalize marijuana — whether for medicinal use only or for recreational use.
WASHINGTON, July 17, 2017 /Weed Wire/ — A meeting scheduled by the President’s Commission on Combating Drug Addiction and the Opioid Crisis for this afternoon has been postponed until July 31, 2017.
WASHINGTON, July 13, 2017 /Weed Wire/ — Across the nation, opioid-related deaths and fatalities are decreasing in states that have medical cannabis programs, but the benefits are limited due to a lack of accurately labeled and tested cannabis products.
A former steel town in Pennsylvania has turned to medical marijuana for an economic boost, taking direction from a Canadian town that made a similar move.
WASHINGTON, June 16, 2017 /Weed Wire/ — Today, June 16th, Governor Chris Christie (NJ) will chair the first meeting of the President’s commision on Drug Addiction and Combating Opioid abuse. Americans for Safe Access has submitted comments to the Commission detailing how medical cannabis can be used as a tool in fighting the opioid epidemic.
Kentucky’s criminal ban on medical marijuana is being challenged in a lawsuit that says its use could help combat the state’s opioid addiction woes.
TRENTON, N.J., May 15, 2017 /Weed Wire/ — The New Jersey CannaBusiness Association (NJCBA), the state’s leading business advocacy group for expanding access to medical cannabis and responsible adult-use of cannabis, fully endorses Senator Nicholas Scutari’s adult-use cannabis legislation.
According to a new poll by SurveyMonkey and BudTrader.com, a medical marijuana marketplace, 87 percent of 152 NFL players support the use of medical marijuana in states where it’s already legal.
SANTA FE, N.M., April 7, 2017 /Weed Wire/ — On Friday, April 7, New Mexico could become the first state in the nation to specifically list opioid use disorder as medical condition that qualifies for access to the state medical marijuana program.
SANTA FE, N.M., March 20, 2017 /Weed Wire/ — Late Friday night, the New Mexico State Senate approved a bill that would make changes to New Mexico’s medical marijuana law.
SANTA FE, N.M., Nov. 4, 2016 /Weed Wire/ — Today pain specialists, people recovering from addiction, community members, and drug policy reformers joined together to call for the inclusion of medical cannabis in New Mexico’s response to heroin and opioids.
On Nov. 16, 2016, Marijuana Investor Summit will talk at the Palms Casino Resort in Las Vegas, Nevada, on how investing in medical marijuana research could help tackle the opioid crisis among the nation.
A U.S. ex-pharmaceutical sales representative accused of paying kickbacks to induce doctors to write prescriptions for an opioid drug is asserting he has a constitutional right to continue smoking marijuana so he can remain clear-headed for his defense. “It is a very creative defense,” said Keith Stroup, the legal counsel and founder of NORML, a…
DENVER, Sept. 27, 2016 /Weed Wire/ — On Wednesday, September 28th from 7PM to 10 PM, Cultivated Synergy will host the Denver-based organization’s 9th cannabis conference in support of cannabis research during Pain Awareness Month.
On Aug. 18, 2016, the West Virginia Center on Budget and Policy announced that it had released a report that examines how marijuana legalization could affect the state’s budget, prison system and chronically ill.
CHARLESTON, W.VA., Aug. 18, 2016 /Weed Wire/ — Legislation has been introduced in West Virginia for years to either legalize medical marijuana or reduce the criminal penalties for marijuana possession. What would it mean to the state if it were to modernize its marijuana laws?
WASHINGTON, Aug. 9, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) released the Medical Cannabis Access for Pain Treatment: A Viable Strategy to Address the Opioid Crisis report to educate legislators and health practitioners on the benefits of medical cannabis as a treatment option for the millions of patients suffering from chronic pain.
FALMOUTH, Maine, May 6, 2016 /Weed Wire/ — One of the world’s leading medical cannabis experts, Dr. Dustin Sulak, will on Tuesday May 10th, present a free to attend and view seminar that provides a solution to the opioid addiction epidemic sweeping the country.
In Maine, medical marijuana activists are hoping to convince state lawmakers to expand the state’s list of qualifying conditions to include one of the most pressing medical conditions in the United States: opioid addiction.
At a U.S. Senate Aging Committee hearing entitled, “Opioid Use Among Seniors – Issues and Emerging Trends,” on Feb. 24, 2016, Sen. Elizabeth Warren, D-Massachusetts, discussed how investing in medical marijuana research could help tackle the opioid crisis among senior citizens.
With the rise in abuse of prescription medication and opioid related deaths, one U.S. Senator is calling on the Centers for Disease Control to examine medical marijuana as a possible solution.
Weekly CannaBit for the week of Oct. 26, 2015: Ohio’s marijuana legalization debate is taking place amid an explosion of opioid abuse in the state. Since 2002, overdoses from all opioids have increased 347%.
Weekly CannaBit for the week of Sept. 28, 2015: The number of patients in Vermont’s substance abuse programs being treated for marijuana has trended slightly downward from 1,419 patients in 2004 to 1,279 in 2013.
The marijuana movement has witnessed some incredible advances in a relatively short period of time.
For years, legislators and law enforcement have been stumped on how to curb abuse; however, according to a new study, the solution may be as simple as legalizing medical marijuana.
It has been 15 years since the advent of medical marijuana in the United States. A new study published by JAMA Internal Medicine sought to determine the effect the availability of legal medical marijuana has on the rate of opioid overdoses in states where patients have access to medical marijuana.